Chronic Myeloproliferative Disorders Active Not Recruiting Phase 2 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00544115Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersTreatment